Proposed Labor-HHS funding invoice may put endocrine analysis, illness prevention, and remedy in danger

The Endocrine Society opposes extreme funding cuts proposed within the Home Labor, Well being and Human Providers, Schooling, and Associated Companies (Labor-HHS) funding invoice that will put life-saving endocrine analysis, illness prevention, and remedy in danger.

The Home Appropriations Committee is planning to mark up the Labor-HHS funding invoice earlier than Congress leaves for its August recess.

The proposed funding ranges within the Labor-HHS invoice would hurt America’s public well being infrastructure and limit analysis investments wanted to develop next-generation cures. Reducing funding will scale back or eradicate providers which can be important to defending the nation’s well being.

The Society is the biggest skilled group for researchers who examine and clinicians who deal with endocrine circumstances, together with diabetes, weight problems, osteoporosis, thyroid circumstances, most cancers, and reproductive circumstances. Within the area of endocrinology, the proposed cuts would:

• Scale back or eradicate profitable diabetes prevention packages that defend susceptible People.
• Slash fundamental and scientific analysis to find new remedies and cures for endocrine ailments, together with most cancers, weight problems, and infertility.
• Make aggressive grant funding much more tough to realize, which is able to discourage early profession researchers from becoming a member of the biomedical analysis pipeline, shrink the workforce, and have impacts on well being analysis for many years to return.

The proposed L-HHS appropriations invoice represents a 28% minimize under Fiscal Yr 2023 ranges and contains:

• A 14% minimize to the Division of Well being and Human Providers.
• An almost $4 billion minimize for the Nationwide Institutes of Well being (NIH) and deep cuts for the Superior Analysis Initiatives Company for Well being (ARPA-H).
• Devastating cuts to the Facilities for Illness Management and Prevention (CDC).

The Endocrine Society calls on Congress to construct on the investments made within the FY 2023 L-HHS funding invoice and reject the proposed FY 2024 invoice. Reducing funding to well being packages places the well being and well-being of the sufferers our members deal with and all People in danger. It threatens the power to conduct lifesaving endocrine analysis, limits endocrinologists’ capability to supply preventive care, and it damages the well being care and analysis workforce.